Article
Characterization of monoclonal antibodies against altered (T103I) amidase from Pseudomonas aeruginosa.
Molecular biotechnology - 1 Jul 2005
Martins Sónia, Karmali Amin, Andrade Jorge, Custódio Ana, Serralheiro Maria Luísa
Abstract excerpt
Monoclonal antibodies (MAbs) against mutant (T103I) amidase from Pseudomonas aeruginosa were raised by hybridoma technology. To select MAbs suitable for immunoaffinity chromatography, hybridoma clones secreting polyol-responsive MAbs (PR-MAbs) were screened that bind antigen tightly but release under mild and nondenaturing elution conditions. It was found that about 10% of enzyme-linked immunosorbent assay...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
